Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravitreal dexamethasone for diabetic macular edema
RBR-59phz5cPhase 2Recruiting
- Sponsor
- Universidade Federal de Pernambuco
- Start
- May 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of dexamethasone in diabetic macular edema (DME), sponsored by Universidade Federal de Pernambuco. Started May 2023; status: recruiting.
02
Drugs
dexamethasone
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on RBR-59phz5c.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-59phz5c.